Cuba launches clinic for chikungunya aftereffects

The Institute of Neurology and Neurosurgery in Cuba has begun a specialized clinic to care for patients with post-chikungunya ailments, particularly those linked to neuropathic pain, joint pain, and paresthesia. This step provides focused treatment for individuals impacted by the mosquito-borne virus.

In Havana on December 23, the Institute of Neurology and Neurosurgery in Cuba has launched a specialized clinic dedicated to treating patients with post-chikungunya ailments. The facility focuses on conditions such as neuropathic pain, joint pain, and paresthesia, which are common lingering effects of the mosquito-borne chikungunya virus that causes fever and severe aches.

Chikungunya can lead to long-term complications that impair daily life for those infected. The new clinic aims to address these persistent issues through comprehensive care. As reported by Prensa Latina, this opening meets the demand for specialized health services in Cuba.

While specific patient numbers are not yet available, the clinic is part of Cuba's public health efforts to manage infectious diseases and their neurological aftermaths. This initiative highlights Cuba's dedication to accessible medical treatment for virus-related conditions.

Artikel Terkait

Comparative illustration of long COVID patients: US woman with severe brain fog and anxiety versus milder symptoms in India, Nigeria, and Colombia, per international study.
Gambar dihasilkan oleh AI

Studi internasional temukan pasien long COVID AS laporkan kabut otak dan gejala psikologis lebih banyak daripada rekan di India dan Nigeria

Dilaporkan oleh AI Gambar dihasilkan oleh AI Fakta terverifikasi

Sebuah studi yang dipimpin oleh Northwestern Medicine pada lebih dari 3.100 orang dewasa dengan long COVID menemukan bahwa peserta yang tidak dirawat inap di Amerika Serikat melaporkan tingkat yang jauh lebih tinggi dari kabut otak, depresi/kecemasan, dan insomnia dibandingkan peserta di Kolombia, Nigeria, dan India—perbedaan yang menurut peneliti kemungkinan mencerminkan faktor budaya dan akses perawatan sebanyak biologi.

Cuban President Miguel Díaz-Canel presented preliminary positive results from clinical trials of the biotechnological drug Jusvinza in patients with chronic post-chikungunya arthritis. The studies, started in December 2025, show notable improvements in provinces like Havana and Matanzas. Experts highlight the drug's safety profile and potential to slow inflammation.

Dilaporkan oleh AI

Cuba has a favorable epidemiological situation in its fight against arboviruses, following a 21 percent decrease in reported febrile cases last week. This improvement highlights effective efforts to control vector-borne diseases such as dengue and zika. Health authorities emphasize the need for ongoing vigilance.

Kenya's Ministry of Health has warned citizens against non-essential travel to parts of India following confirmation of two Nipah virus cases in West Bengal. The risk of the disease spreading to Kenya remains low, but authorities urge strict personal hygiene for travelers. The World Health Organization has verified the outbreak of this rare but serious illness.

Dilaporkan oleh AI

Di Hutan Atlantik Brasil yang menyusut, deforestasi menyebabkan nyamuk semakin banyak makan darah manusia, meningkatkan risiko penyakit seperti demam berdarah dan Zika. Studi baru mengungkapkan bahwa dari makanan darah yang teridentifikasi, sebagian besar berasal dari manusia bukan satwa liar. Adaptasi ini menekankan bagaimana hilangnya habitat mengubah pola penularan penyakit.

Peneliti dari Weill Cornell Medicine dan Wake Forest University School of Medicine telah mengidentifikasi jalur respons stres pada sel imun yang diaktifkan oleh kemoterapi dan menyebabkan kerusakan saraf yang menyakitkan. Pada tikus, memblokir jalur ini dengan obat yang sudah dalam uji coba kanker tahap awal mengurangi tanda-tanda cedera saraf, dan studi kecil pada pasien menunjukkan tes darah mungkin suatu hari bisa memprediksi siapa yang paling berisiko.

Dilaporkan oleh AI

The Don Benito Health Area has confirmed the death of a 15-year-old teenager from meningoencephalitis caused by reactivation of type 6 virus. The death occurred on March 13 at Vegas Altas hospital. Health authorities state that this variant does not require epidemiological surveillance or specific protocols.

 

 

 

Situs web ini menggunakan cookie

Kami menggunakan cookie untuk analisis guna meningkatkan situs kami. Baca kebijakan privasi kami untuk informasi lebih lanjut.
Tolak